In the ordinary differential equation (ODE) model of Chiba et al. (1), the binding reaction between Ca
2+ and CaM is computed deterministically using the sequential four-step Ca 2+ binding model of Holmes et al. (2) . This model includes cooperative Ca 2+ binding within each CaM lobe (C-terminal and N-terminal lobe) and assumes that the C-terminal Ca 2+ binding sites are occupied before the N-terminal sites. CaM binds two Ca 2+ ions to its C-terminal lobe with a high affinity (K d of ~1-2 µM) and two Ca 2+ ions to its N-terminal lobe with a low affinity (K d of ~2.6-13 µM). It is therefore expected that CaM will bind four Ca 2+ 
All kinetic rate constants (e.g. k -1 , k -2 , k -3 , k -4 …k 1, k 2 , k 3 , k 4 ) have values in agreement with those reported previously (1) as shown in Tables S1 and S2. As shown in Fig. S3 
Changes to the model of Hashambhoy et al. (3)
The following changes were made to the model of Hashambhoy 2. In order to obtain physiologically relevant I CaL facilitation (Fig. S4A) , the LCC dephosphorylation rate is reduced by a factor of 2. This parameter (new value 0.6 units PP2A x (units CaMKII) -1 ) controls the peak I CaL simulated in the I CaL facilitation (voltage clamp) protocol as illustrated in Fig. S4A . This value is similar to that originally published by Hashambhoy et al (4).
3. The mode 2 mean open time is reduced from 10 ms to 6 ms which lies within the experimental range of 5 to 10 ms (5, 6 ). This reduction is achieved by scaling the mode 2 rate of LCC closing by 1.67 as compared to that of Hashambhoy et al. (3) .With this new value, the model has a 12-fold reduction in the LCC closing rate for mode 2 versus mode 1. This adjustment was necessary to obtain stable action potentials.
4. Following incorporation of the proposed CaMKII activation model into our canine cardiac myocyte model (3), the conductance of I Kr (G Kr ) is increased by 70%. This scaling was derived from recent experimental data of Szabo et al. (7) . These data indicate a far greater density of I Kr (e.g. 0.8 pA/pF) at depolarized test potentials (e.g. + 40 mV) than those measured in earlier studies. As a result of this change, the model simulates a peak I Kr density = 0.5 pA/pF at 1 s PCL pacing which is consistent with the reported experimental value of 0.55 pA/pF (8). 
Modeling the effects of H 2 O 2 on CaMKII-PP1
Using both experimental in vivo and in vitro ischemia models, O'Loghlen et al. (14) demonstrated that protein phosphatase 1 (PP1) activity is inhibited upon H 2 O 2 -treatment which results in increased target phoshorylation levels; however, the mechanisms underlying this observation remain unknown. To explore the potential role of oxidative stress on CaMKII dephosphorylation rate due to PP1 inhibition, we have introduced an inhibitory constant (K mROS ) in the catalytic rate of PP1 (k cat_PP1 ) defining a new parameter (k cat_PP1 new ) as follows:
For low values of K mROS (e.g. 0.1 mM) and increased oxidative stress ([H 2 O 2 ] = 1 mM) ( Fig.  S5) , the model predicts significant CaMKII autophosphorylation which is consistent with the experimental evidence from Song et al. (15) . Without this inhibitory constant, the model is unable to reproduce the experimentally observed degree of CaMKII autophosphorylation.
Equation Rates and Parameters
Most of the rates of the stochastic CaMKII model are identical to those published previously by Chiba et al.
(1) with the exception of the phosphorylation rate (referred to as B1 in Fig. 1A ) and those that have been newly introduced in this model (e.g. rates C2, C3 involved in the oxidation pathway). More specifically, the phosphorylation rate B1 is described by an expression similar to that used by Hashambhoy et al. (4), based on the assumption that a CaMKII monomer can be phosphorylated by an adjacent monomer from either side: Figure S18 Figure S18 . Simulated APs, all of which exhibit EADs for a 6 s PCL pacing protocol, under conditions of elevated oxidative stress (200 µM H 2 O 2 ) including the full range of experimentally observed changes in I Na properties as seen with CaMKII overexpression; including a shift in steady-state inactivation and a slowing of recovery from inactivation. Relevant I Na model parameters (referred to as P 1b5 , P 1b6 and P 1a7 in the model of Grandi et al. (11)) were adjusted to the values reported by Grandi et al. (11) for CaMKII overexpression. [LTRPNCa]
Supplemental Tables
(mM) We would like to clarify that the notion of "steady-state" for unstable APs (e.g. EADs) refers to the condition in which the SR Ca 2+ cycles in a stable repeating pattern on a beat-to-beat basis. In the case of a 2 s PCL pacing protocol, steady state values are obtained following 60 beats. (25) 
